Review oncologic, endocrine & metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapy

Expert Opinion on Therapeutic Patents

Volumn 5, Issue 12, 1995, Pages 1269-1285

  Graham, Samuel L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; B 581; CARBOXYLIC ACID POLYMER; CYCLOBUTANE DERIVATIVE; CYSTEINE; DITERPENE; ENZYME INHIBITOR; FARNESYL DERIVATIVE; FARNESYLAMINE; L 731734; L 731735; L 739787; LIMONENE DERIVATIVE; MANUMYCIN; MEDRONIC ACID DERIVATIVE; MUTANT PROTEIN; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER; NUCLEAR FACTOR; OLEYLAMINE; PEPTIDE DERIVATIVE; PHOMOIDRIDE A; PIPERAZINE DERIVATIVE; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; TERPENE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZARAGOZIC ACID;

CANCER CHEMOTHERAPY; CELL DIVISION; CELL GROWTH; CELL TRANSFORMATION; HUMAN; NONHUMAN; ONCOGENE; PATENT; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0028784266     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.5.12.1269     Document Type: Article

References (70)

1. Ras and human tumors
2. KYRIAK1S JM: Raf meets ras: com-pleting the framework of a signal transduction path-way
3. p21 Ras is modified by a farnesyl isoprenoid
4. molecular mechanisms and functional consequences. Annu. Rev. Biochem
5. GOLD-STEIN JL: Sequence requirement for peptide recognition by rat brain p21r" protein famesyltransferase
6. O'HARA MB, GARSKY VM, MARSHALL MS, POMPLIANO DL, GIBBS JB: Sequence dependence of protein isoprenylation
7. A protein geranylgeranyl transferase from bovine brain: implications for protein prenyla-tion specificity
8. CaaX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB
9. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyl-transferases farnesyltransferase and geranyigeranyl-transferase-1 in Saccbaromyces cerevistae
10. KIM S-H: Prenylation of mammalian Rasprotein in Xenopus oocytes
11. Nonfarnesylated tetrapeptide inhibitors of protein farnesyhransferase
12. Peptidomimetic inhibitors of ras farnesyla-don and function in whole cells
13. Pseudopeptide inhibitors of ras farnesyl-protein transferase
14. Peptide based p21"8 farnesyl transferase inhibitors: systematic modification of the tetrapeptide CAiAzX motif
15. Selective inhibition of ras-dependent trans-formation by a farnesyltransferase inhibitor
16. Benzodiawbpine pepti-domitnetic inhibitors of farnesyltransferase
17. Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferase
18. Potent inhibition of human tumor p2 1
19. Design and struc-tural requirements of potent peptidomimetic inhibitors of p21 farnesyltransferase
20. Peptidomiinetic inhibitors of p21ras farnesyltransferase - hydrophobic functionaliza-don leads to disruption of p21as membrane association in whole cells
21. A non-peptide mimetic of Ras-CaaX: selective inhibition of farnesyltransferase and Ras processing
22. Protein farnesyltransferase inhibi-tors block the growth of ras -dependent tumors in nude-mice
23. O'NEILL TJ, SCHABER MD, GIBBS JB, OLIFF A: Inhibition of farnesyltransferase Induces regression of mammary and salivary carcino-mas in ras transgenic mice
24. Synthesis and biological activity of ras farnesyl-protein transferase inhibitors
25. Cysteine and methion-ine linked by carbon pseudopeptides inhibit farnes-yi transferase
26. Benzodiazepine pepti-domhnetics - potent inhibitors of ras farnesylation in animal cells
27. Conformation of a heptapeptide substrate bound to protein farnesyltrans-ferase
28. NMR studies of novel inhibitors bound to farnesyl-pro-tein transferase
29. Stereochemisiry of the benzodiazepine based Ras farnesyltransferase Biomed
30. SMITH RL: Pseuciodipeptkle inhibitors of protein farnesyltrans-ferase
31. Phenol based tripeptide inhibitors of Ras farnesyl-pro-tein transferase
32. Steady-state kinetic mechanism of Ras farnesylprotein transferase
33. Selective inhibition of farnesyl-protein transferase blocks Ras processing in vivo
34. Different analogs of farnesyl pyro-phosphate inhibit squalene synthase and protein-far-nesyltransferase to different extents
35. Farnesyl diphosphate-based inhibi-tors of ras farnesyl-protein transferase
36. Ras farnesylation as a target for novel antitumor agents
37. Farnesylamine - an inhibitor of farnesylation and growth of ras-transformed cells
38. Effects of long-chain fatty amines on the growth of ras-transformed NIH3T3 cells
39. Iso-lation and structure of chaetomeilic acids A and B from Chaetomella acuttseta - farnesyl pyrophosphate mimic Inhibitors of Ras farnesylprotein transferase
40. Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protein transferase
41. Zaragozic acid-D and acid-D2 - potent inhibitors of squalene syntbasy- and of ras farnesyl-protein transferase
42. Actinoplanic add A: a macrocyclic polycarboxylic add which is a potent inhibitor of Ras farnesyl-protein transferase
43. VAN DER PYL D, CANS P, DEBERNAND JJ, HERMAN F, LELIEVRE Y, TAHRAOUI L, VUELHORONE M
44. Identification of ras farnesyhransferase inhibitors by microbial screening Proc
45. Bisubstrate Inhibitors of farnesyltransferase - a novel class of spe-dfic inhibitors of Ras transformed cells
46. Phosphinyl add-based bisubstrate analog inhibitors of ras farnesyl-protein transferase
47. Rational design of potent car-boxylic-acid based bisubstrate inhibitors of Ras farnesyl-protein transferase
48. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete L Producing strain, fermentation, isolation and biologi-cal-activity
49. Pepticinnanains, new farnesyl-protein transferase inhibitors produced by an actinomycete
50. NALLIN-OLM-STEAD M, JENKINS RG, LINGHAM RB, SILVERMAN KC, GIBBS JB: Fusidienol: a novel inhibitor of Ras farnesyl-protein transferase from Fusidtum griseum
51. Cylindrol-A - a novel inhibitor of ras farnesyl-protein transferase from Cylindrocarpon lu-cidum